- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
GPS driving: a digital biomarker for preclinical Alzheimer disease ; volume:13 ; number:1 ; day:14 ; month:6 ; year:2021 ; pages:1-9 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (14.6.2021), 1-9, 12.2021
- Urheber
-
Bayat, Sayeh
Babulal, Ganesh M.
Schindler, Suzanne E.
Fagan, Anne M.
Morris, John C.
Mihailidis, Alex
Roe, Catherine M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00852-1
- URN
-
urn:nbn:de:101:1-2021100421451159296260
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bayat, Sayeh
- Babulal, Ganesh M.
- Schindler, Suzanne E.
- Fagan, Anne M.
- Morris, John C.
- Mihailidis, Alex
- Roe, Catherine M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
Developing preclinical models of neuroblastoma: driving therapeutic testing
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
APP mouse models for Alzheimer's disease preclinical studies
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Possibilities of high precision GPS data in autonomous driving
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
Developing preclinical models of neuroblastoma: driving therapeutic testing
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
APP mouse models for Alzheimer's disease preclinical studies
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Possibilities of high precision GPS data in autonomous driving
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
Developing preclinical models of neuroblastoma: driving therapeutic testing
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
APP mouse models for Alzheimer's disease preclinical studies
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Possibilities of high precision GPS data in autonomous driving
Neue multimodale Biomarker der Alzheimer-Erkrankung